Tag: STRIDES SHASUN

HOME » STRIDES SHASUN
» 2019-04-02

Pharmaceutical Strides Pharma Science Ltd said wholly owned subsidiary Vensun Pharmaceuticals and partner Pharmaceutics International received approval from the United States Food and Drug Administration to launch a generic equivalent […]

» 2019-03-27

Pharmaceutical major Strides Pharma Science Ltd said it received approval from the United States  Food and Administration for its greenfield oral medication facility in Singapore, giving a boost to the […]

» 2019-02-06

Strides Pharma said the US Food & Drug Administration completed an inspection of the company’s primary manufacturing facility in India with zero adverse observations. The company’s formulations facility at KRSG […]

» 2018-05-29

Pharma major Strides Shasun denied rumors that its auditors had resigned. The rumors, coming close on the heels of a similar development at Manpasand Beverages, had impacted the company’s share […]

» 2018-05-09

Pharma player Strides Shasun said it has agreed in principle to merge its Australian business with the Australian operations of peer Apotex. Both have substantial businesses in Australia; Strides under […]

» 2018-04-12

Pharma manufacturer Strides Shasun said it received approval from the United States Food and Drug Administration to sell a generic version of Merck’s Periactin tablets. The US market for Cyproheptadine […]

» 2018-02-26

Pharma major Strides Shasun said it has decided to launch the ‘over the counter’ version of ulcer drug Ranitidine in 150 mg dosage in the US markets immediately. Strides Shasun […]

» 2018-01-29

Cipla and Strides Shasun, two Indian pharmaceutical companies, both said they have started shipping generic versions of Gilead Sciences’ HIV drug Viread after patent protection expired last week. Viread is […]

» 2017-12-04

Pharma company Eris LifeSciences said it has completed its purchase of the India branded generics of Strides Shasun for Rs 500 cr in cash. “We now wish to confirm that […]

» 2017-11-22

Strides Shasun Limited said it received approval from the United States Food & Drug Administration (USFDA) to launch a generic version of Diamox Tablets. The primary use of the Acetazolamide […]

» 2017-11-20

Pharma major Strides Shasun said it agreed to sell its India branded generics business to Eris LifeSciences Limited for Rs 500 cr in cash. “This transaction is the outcome of […]

» 2017-07-24

Pharma company Strides Shasun said it had received approval allergy drug Cetirizine Hydrochloride in the US. “The US market for Cetirizine Hydrochloride Capsules (Softgel) is approximately USD 60 mln, with […]

» 2017-07-03

Pharmaceutical company Strides Shasun said it received approval from the United States Food & Drug Administration to sell nausea drug Promethazine Hydrochloride in the country. The US market for Promethazine […]

» 2016-08-25

Pharma company Strides Shasun announced that it received the United States Food & Drug Administration (USFDA) approval for Polyethylene Glycol powder to treat occasional constipation. The powder when consumed as […]

» 2016-08-24

Pharma company Strides Shasun announced that it received the United States Food & Drug Administration (USFDA) approval for generic Ranitidine Tablets, used to treat and prevent ulcers in the stomach […]